Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$235.51 - $267.98 $26,612 - $30,281
-113 Reduced 8.92%
1,154 $288,000
Q1 2024

May 03, 2024

BUY
$224.58 - $256.19 $62,657 - $71,477
279 Added 28.24%
1,267 $316,000
Q4 2023

Feb 07, 2024

BUY
$185.1 - $233.13 $2,221 - $2,797
12 Added 1.23%
988 $228,000
Q3 2023

Nov 09, 2023

BUY
$233.08 - $265.59 $11,420 - $13,013
49 Added 5.29%
976 $242,000
Q2 2023

Jul 28, 2023

BUY
$224.99 - $256.14 $2,249 - $2,561
10 Added 1.09%
927 $222,000
Q1 2023

May 03, 2023

SELL
$239.75 - $277.0 $6,952 - $8,033
-29 Reduced 3.07%
917 $231,000
Q4 2022

Feb 01, 2023

SELL
$241.42 - $282.29 $18,830 - $22,018
-78 Reduced 7.62%
946 $251,000
Q3 2022

Nov 09, 2022

SELL
$247.06 - $1507.4 $18,035 - $110,040
-73 Reduced 6.65%
1,024 $265,000
Q2 2022

Nov 16, 2022

BUY
$237.11 - $299.66 $17,309 - $21,875
73 Added 7.13%
1,097 $278,000
Q2 2022

Aug 01, 2022

SELL
$237.11 - $299.66 $78,246 - $98,887
-330 Reduced 23.13%
1,097 $278,000
Q1 2022

May 02, 2022

BUY
$257.27 - $315.76 $367,124 - $450,589
1,427 New
1,427 $419,000
Q2 2020

Jul 28, 2020

SELL
$128.7 - $176.83 $305,019 - $419,087
-2,370 Closed
0 $0
Q1 2020

Apr 24, 2020

SELL
$121.39 - $169.05 $17,358 - $24,174
-143 Reduced 5.69%
2,370 $328,000
Q4 2019

Jan 31, 2020

SELL
$133.47 - $153.48 $51,652 - $59,396
-387 Reduced 13.34%
2,513 $386,000
Q3 2019

Nov 01, 2019

SELL
$135.4 - $146.47 $58,222 - $62,982
-430 Reduced 12.91%
2,900 $419,000
Q2 2019

Aug 08, 2019

SELL
$124.88 - $143.73 $621,527 - $715,344
-4,977 Reduced 59.91%
3,330 $476,000
Q1 2019

May 09, 2019

BUY
$97.62 - $132.29 $588,941 - $798,105
6,033 Added 265.3%
8,307 $1.1 Million
Q4 2018

Feb 08, 2019

BUY
$94.85 - $109.54 $215,688 - $249,093
2,274 New
2,274 $234,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Hallmark Capital Management Inc Portfolio

Follow Hallmark Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hallmark Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hallmark Capital Management Inc with notifications on news.